Crossmark

Efficacy and safety of pembrolizumab in the treatment of advanced hepatocellular carcinoma: a systematic review and meta-analysis

Published Online: 2025-04-02

Published Print: 2025-06

Authors

Tang, Mingyang

Liu, Tao

Zhang, Yukun

Ding, Jun
License Information

Text and Data Mining valid from 2025-04-02

Version of Record valid from 2025-04-02
More Information

Article History

Received: 3 January 2025

Accepted: 21 March 2025

First Online: 2 April 2025

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current